OKLAHOMA CITY – A low-dose form of medical marijuana may soon be used by adults afflicted with several medical conditions including epilepsy, multiple sclerosis and cancer.
A state Senate panel approved House Bill 2835 Monday by a 9-0 vote to allow people 18 and over to receive cannabidiol (CDB) oil and tetrahydrocannabinol (THC), the active ingredient in marijuana, within clinic settings and trials. The amount of THC is limited by law to three-tenths of a percent.
The proposal, if approved by the full Senate, would allow doctors to prescribe the CBD oil to patients with intractable nausea and vomiting, appetite stimulation associated with chronic wasting diseases, such as cancer, epilepsy and spasticity due to Multiple Sclerosis or paraplegia.
In 2015, the Oklahoma Legislature approved the same measure for children under 18.
Read more
